Lawrence S. Goldstein
Northeast Ohio Medical University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Lawrence S. Goldstein.
Pediatric Pulmonology | 2000
Amy B. Goldstein; Lawrence S. Goldstein; Mary Perl; Marcus T. Haug; Alejandro C. Arroliga; Paul C. Stillwell
Central nervous system (CNS) complications occur more frequently in cystic fibrosis (CF) patients than other lung transplant recipients. The purpose of this study was to compare CF patients with and without CNS complications following lung transplantation, to identify risk factors for CNS events. Records of 21 patients with CF who underwent lung transplant between 1991–1996 were reviewed. Data were collected on multiple variables, including: age at transplant; gender; cytomegalovirus (CMV) status; cholesterol and triglyceride levels; sinusitis; percent ideal body weight (IBW); body mass index (BMI); augmented immunosuppression, acute lung rejection episodes (ALR); cyclosporine doses; electrolytes; magnesium, blood urea nitrogen (BUN), and creatinine levels; and 6‐month survival. CNS complications identified were seizures, severe headaches (HA), strokes, or confusional episodes.
Journal of Hospital Medicine | 2008
Konstantinos Marmagkiolis; Ioannis G. Nikolaidis; Themos Politis; Lawrence S. Goldstein
Stroke remains an increasing worldwide cause of disability and mortality, and it is the second leading cause of death in industrialized countries. Patients with atrial fibrillation form a unique group with increased risk of cardioembolic stroke. Despite the widespread application of the National Institutes of Health stroke scale and guidelines, patients with atrial fibrillation represent a clinically challenging group that deserves a special approach during the acute stroke phase. The mechanism of stroke in these patients is either cardioembolic [especially with an international normalized ratio (INR) < 2.0] or hemorrhagic (especially with INR > 5.0) (Figure 1). Atrial fibrillation with valvular heart disease significantly increases the risk for ischemic stroke. Specifically, patients with mitral stenosis who develop atrial fibrillation increase their risk of cardioembolism by 3 to 7 times. Many patients with atrial fibrillation still develop ischemic or hemorrhagic stroke despite appropriate use of anticoagulation. Prior stroke, transient ischemic attacks, congestive heart failure, hypertension, age > 75, and diabetes mellitus are all well-established risk factors for the development of stroke in patients with atrial fibrillation. The CHADS-2 score is the most widely studied and clinically used method for stratifying patients with nonrheumatic atrial fibrillation. In our review, we present the most recent clinical guidelines and trends for the approach to and management of this patient group.
Chest | 1998
Lawrence S. Goldstein; Mani S. Kavuru; Patricia Curtis-McCarthy; Howard A. Christie; Carol Farver; James K. Stoller
Chest | 2000
Bipin D. Sarodia; Lawrence S. Goldstein; Daniel Laskowski; Atul C. Mehta; Alejandro C. Arroliga
Clinical Pulmonary Medicine | 1999
Lawrence S. Goldstein; Mani S. Kavuru; James K. Stoller
Journal of Bronchology | 1997
Lawrence S. Goldstein; James J. Walsh; Atul C. Mehta
Chest | 2017
Diwas Shahi; Ajai Rajabalan; Jonathan BarreraCalix; Sunil Paudel; Tamer Said Ahmed; Samir Patel; Ritha Kartan; Lawrence S. Goldstein
Chest | 2016
Karthik Vijayan; Promish Shrestha; Manuel Bautista; Lawrence S. Goldstein; Bhiputhi Neupane
Chest | 2009
Abhijit Duggal; Hardeep Rai; Bacel Nseir; Anthony Cutrona; Lawrence S. Goldstein
Chest | 2009
Abhijit Duggal; Konstantinos Marmagkiolis; Lawrence S. Goldstein